300 related articles for article (PubMed ID: 22119426)
1. MicroRNA networks surrounding APP and amyloid-β metabolism--implications for Alzheimer's disease.
Schonrock N; Matamales M; Ittner LM; Götz J
Exp Neurol; 2012 Jun; 235(2):447-54. PubMed ID: 22119426
[TBL] [Abstract][Full Text] [Related]
2. In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs.
Smith P; Al Hashimi A; Girard J; Delay C; Hébert SS
J Neurochem; 2011 Jan; 116(2):240-7. PubMed ID: 21062284
[TBL] [Abstract][Full Text] [Related]
3. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice.
Liu W; Liu C; Zhu J; Shu P; Yin B; Gong Y; Qiang B; Yuan J; Peng X
Neurobiol Aging; 2012 Mar; 33(3):522-34. PubMed ID: 20619502
[TBL] [Abstract][Full Text] [Related]
5. Amino-truncated amyloid beta-peptide (Abeta5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer's disease brain.
Takeda K; Araki W; Akiyama H; Tabira T
FASEB J; 2004 Nov; 18(14):1755-7. PubMed ID: 15364896
[TBL] [Abstract][Full Text] [Related]
6. Molecular network of microRNA targets in Alzheimer's disease brains.
Satoh J
Exp Neurol; 2012 Jun; 235(2):436-46. PubMed ID: 21945006
[TBL] [Abstract][Full Text] [Related]
7. The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease.
Ling S; Zhou J; Rudd JA; Hu Z; Fang M
Anat Rec (Hoboken); 2011 Aug; 294(8):1307-18. PubMed ID: 21717585
[TBL] [Abstract][Full Text] [Related]
8. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.
Grimm MO; Kuchenbecker J; Rothhaar TL; Grösgen S; Hundsdörfer B; Burg VK; Friess P; Müller U; Grimm HS; Riemenschneider M; Hartmann T
J Neurochem; 2011 Mar; 116(5):916-25. PubMed ID: 21214572
[TBL] [Abstract][Full Text] [Related]
9. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
10. From synaptic spines to nuclear signaling: nuclear and synaptic actions of the amyloid precursor protein.
Octave JN; Pierrot N; Ferao Santos S; Nalivaeva NN; Turner AJ
J Neurochem; 2013 Jul; 126(2):183-90. PubMed ID: 23495999
[TBL] [Abstract][Full Text] [Related]
11. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease and the amyloid β-protein.
Walsh DM; Teplow DB
Prog Mol Biol Transl Sci; 2012; 107():101-24. PubMed ID: 22482449
[TBL] [Abstract][Full Text] [Related]
14. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
[TBL] [Abstract][Full Text] [Related]
15. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in Alzheimer's disease.
Delay C; Mandemakers W; Hébert SS
Neurobiol Dis; 2012 May; 46(2):285-90. PubMed ID: 22285895
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
18. Proteasome-mediated degradation of the C-terminus of the Alzheimer's disease beta-amyloid protein precursor: effect of C-terminal truncation on production of beta-amyloid protein.
Nunan J; Williamson NA; Hill AF; Sernee MF; Masters CL; Small DH
J Neurosci Res; 2003 Nov; 74(3):378-85. PubMed ID: 14598314
[TBL] [Abstract][Full Text] [Related]
19. Role of the APP promoter in Alzheimer's disease: cell type-specific expression of the beta-amyloid precursor protein.
Lahiri DK; Ge YW
Ann N Y Acad Sci; 2004 Dec; 1030():310-6. PubMed ID: 15659812
[TBL] [Abstract][Full Text] [Related]
20. [Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes].
Fukatsu R; Tsuzuki K; Hayashi Y; Takamaru Y; Sasaki N; Yoshida T; Hatakeyama Y; Fuji N; Takahata N
Hokkaido Igaku Zasshi; 1997 Jan; 72(1):3-11. PubMed ID: 9086357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
